Overview And Management Of The Neuroendocrine Cancer Of The Bladder With Two Cases

Small cell neuroendocrine carcinomas are rare (less than 1%) but rather aggressive tumors of the bladder with poor prognosis. The 5-year survival rate is around 14-16%. In this paper, we present two cases: one male at the age of 73 years and one female at the age of 65 years, who were diagnosed with small cell neuroendocrine tumors as a result of the examination of trans urothelial resection (TUR) material performed in 2019. These aggressive tumors are very rare and require multimodal treatment protocols. There are case series in the literature; these series consist of a limited number of patients.